Last updated: July 11, 2026

Application No. 19/429,318

Untitled Application

Unknown

Filed

Priority

Nov 21, 2013 — CIP of 14/086,696 +7 more

Examiner

CANELLA, KAREN A

Art Unit

Tech Center

APEIRON Biologics GmbH

Assignee

Apeiron Biologics GmbH

OA Round

1 (Non-Final)

This examiner grants 63% of cases after interview

— +32.8% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 1123 resolved cases, 2023–2026

Examiner Intelligence

CANELLA, KAREN A View full profile →

Grants 63% of resolved cases

Career Allowance Rate

703 granted / 1123 resolved

+2.6% vs TC avg

Strong +33% interview lift

Without

With

+32.8%

Interview Lift

resolved cases with interview

Typical timeline

3y 5m

Avg Prosecution

50 currently pending

Career history

1173

Total Applications

across all art units

Statute-Specific Performance

§101

2.2%

-37.8% vs TC avg

§103

36.3%

-3.7% vs TC avg

§102

12.1%

-27.9% vs TC avg

§112

14.8%

-25.2% vs TC avg

Black line = Tech Center average estimate • Based on career data from 1123 resolved cases

Prosecution Timeline

Apr 10, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/701,634

Patent 12648948

Methods and Compositions for Treating Cancer

4y 2m to grant Granted Jun 09, 2026

19/229,907

Patent 12630652

BISPECIFIC ANTIBODY AND USE THEREOF

11m to grant Granted May 19, 2026

17/438,741

Patent 12624102

CD147 CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE

4y 8m to grant Granted May 12, 2026

17/822,051

Patent 12622956

METHODS AND VACCINES FOR INDUCING IMMUNE RESPONSES TO MULTIPLE DIFFERENT MHC MOLECULES

3y 8m to grant Granted May 12, 2026

18/040,498

Patent 12622977

ANTIBODY DRUG CONJUGATE

3y 3m to grant Granted May 12, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

63%

Grant Probability

95%

With Interview (+32.8%)

3y 5m

Median Time to Grant

Low

PTA Risk

Based on 1123 resolved cases by this examiner. Grant probability derived from career allowance rate.